Arcutis Biotherapeutics, Inc. (ARQT) vs iRhythm Technologies, Inc. (IRTC)
A side-by-side comparison of Arcutis Biotherapeutics, Inc. and iRhythm Technologies, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ARQT
Arcutis Biotherapeutics, Inc.
$24.72HealthcareDelayed quote: Oct 6, 2026, 11:25 AM EDT
IRTC
iRhythm Technologies, Inc.
$107.03HealthcareDelayed quote: Oct 6, 2026, 11:25 AM EDT
Total return — ARQT vs IRTC
growth of $100 · dividends reinvested · last 7yARQT +15.4% (+2.1%/yr)IRTC +22.7% (+3.0%/yr)IRTC compounded faster over this window
ARQT IRTC
ARQT vs IRTC: by the numbers
- •IRTC is the larger company ($3.52B vs $3.09B market cap).
- •ARQT is profitable (6.15% net margin) while IRTC runs a net loss (-1.69%).
Metrics side by side
Valuation
| Metric | ARQT | IRTC |
|---|---|---|
| P/E ratio | 118.57 | N/A |
| Forward P/E | 49.73 | N/A |
| P/S ratio | 6.66 | 4.26 |
| P/B ratio | 14.02 | 18.91 |
| EV / EBITDA | 85.27 | 285.95 |
| FCF yield | 1.27% | 1.11% |
Profitability
| Metric | ARQT | IRTC |
|---|---|---|
| Gross margin | 91.14% | 71.45% |
| Operating margin | -3.25% | -1.17% |
| Net margin | 6.15% | -1.69% |
| ROE | 12.93% | -7.50% |
| ROIC | 9.95% | -1.07% |
Growth (annualized)
| Metric | ARQT | IRTC |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 21.93% |
| Total return CAGR (5Y) | -0.28% | 12.95% |
Frequently asked
- Is ARQT or IRTC more profitable?
- ARQT runs the higher net margin — ARQT at 6.15% versus IRTC at -1.69%.
- How have ARQT and IRTC total returns compared?
- Over the past 5 years, ARQT delivered -0.28% and IRTC delivered 12.95% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Arcutis Biotherapeutics P/E ratioArcutis Biotherapeutics ROEiRhythm Technologies ROEArcutis Biotherapeutics operating marginiRhythm Technologies operating marginArcutis Biotherapeutics revenue growthiRhythm Technologies revenue growthArcutis Biotherapeutics free cash flowiRhythm Technologies free cash flow
Arcutis Biotherapeutics & iRhythm Technologies appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.